Board Diversity Scholarship, Australian Government Office for Women, Australian Institute of Company Directors (2013) Perpetual Trust Scholarship (2011)
Jan Maree Tennent (born 1 January 1960) is an Australianscientist in the biomedical and animal health research sectors, and a member of the Australian Academy of Technology Science and Engineering.[1][2]
Early life and education
Tennent was born in Footscray, Melbourne, Victoria on 1 January 1960. She obtained a Bachelor of Science, in microbiology from the Monash University in Melbourne in 1981. She completed her PhD in 1986 at Monash University. Her PhD thesis was entitled 'Molecular Analysis of Plasmids in Multi-resistant Staphylococci'.
Career
Tennent left Australia in 1986 to do a four-year postdoctoral fellowship with Prof Staffan Normark at Umeå University in Sweden. She researched the genetic mechanism and control of host attachment by uropathogenic Escherichia coli as part of the Normark laboratory's research.[3][4][5][6][7]
Tennet returned to Australia and joined the CSIRO as a senior research scientist. She became the program manager of the Vaccines and Immunology Group in 1997. Tennent has researched and given keynote presentations in the field of biotechnology and animal vaccines.[8]
In 2000, Tennent joined the global biotherapy organisation CSL Limited and later became a member of the CSL Animal Health executive team. Tennent joined the international pharmaceutical company Pfizer in 2004. In 2009, Tennent founded ConnectBio Pty Ltd.[9]
In 2011, Tennent was appointed as the Chief Executive Officer of Biomedical Research Victoria, a body that represents Australia's biomedical research. In 2017, Tennent was elected to the AusBiotech Board.[10]
Tennent has published 35 contributions in international peer-reviewed scientific journals (1984–2006) and eight reviews, theses and book chapters on microbial pathogenesis.[11] She served on research-related committees including the Genetic Manipulation Advisory Committee (now the Office of the Gene Technology Regulator) between 1995 and 2001.
^Marklund, Britt-lnger; Tennent, Jan M.; Garcia, Elisa; Hamers, Anja; Baga, Monika; Lindberg, Frederik; Gaastra, Wim; Normark, Staff an (August 1992). "Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties". Molecular Microbiology. 6 (16): 2225–2242. doi:10.1111/j.1365-2958.1992.tb01399.x. PMID1357526. S2CID34556027.
^Tennent, J. M.; Lindberg, F.; Normark, S. (May 1990). "Integrity of Escherichia coli P pili during biogenesis: properties and role of PapJ". Molecular Microbiology. 4 (5): 747–758. doi:10.1111/j.1365-2958.1990.tb00645.x. PMID1975085. S2CID27745334.
^Norgren., M.; Bága., M.; Tennent, J.M.; Normark, S. (September 1987). "Nucleotide sequence, regulation and functional analysis of the papC gene required for cell surface localization of Pap pili of uropathogenic Escherichia coli". Molecular Microbiology. 1 (2): 169–178. doi:10.1111/j.1365-2958.1987.tb00509.x. PMID2897064. S2CID24884461.